Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Frystyk

Showing results (201-210 of 292) with videos related to

Pageof 30
Sort By:
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 13, 2015
The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and TreatmentUlrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, et al.
Endocrinology|October 6, 2011
Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in miceMaximilian Bielohuby, Michael Schaab, Moritz Kummann, et al.
Cardiology|September 12, 2012
Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionSune Pedersen, Rasmus Mogelvang, Mette Bjerre, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2025
Characterisation of Leydig cell dysfunction in previous illicit androgen usersYeliz Bulut, Niels Brandt-Jacobsen, Rasmus Madsen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2007
Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutationsHoracio M Domené, Paula A Scaglia, Aida Lteif, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 14, 2011
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndromeRasmus Sode-Carlsen, Stense Farholt, Kai Fr Rabben, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 22, 2011
Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48 weeks of physical trainingSara M Gregory, Samuel A Headley, Michael Germain, et al.
The Journal of Physiology|April 19, 2008
Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exerciseMette Hansen, Satu O Koskinen, Susanne G Petersen, et al.
Scandinavian Journal of Gastroenterology|November 4, 2005
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroidsMartin Eivindson, Henning Grønbaek, Jens Nederby Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 29, 2016
Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog TreatmentJakob Dal, Katrine Lundby Høyer, Steen Bønløkke Pedersen, et al.
Pageof 30

Showing results (201-210 of 292) with videos related to

Sort By:
Pageof 30
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 13, 2015
The Circulating IGF System in Hepatocellular Carcinoma: The Impact of Liver Status and TreatmentUlrick Espelund, Henning Grønbæk, Gerda Elisabeth Villadsen, et al.
Endocrinology|October 6, 2011
Serum IGF-I is not a reliable pharmacodynamic marker of exogenous growth hormone activity in miceMaximilian Bielohuby, Michael Schaab, Moritz Kummann, et al.
Cardiology|September 12, 2012
Osteoprotegerin predicts long-term outcome in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary interventionSune Pedersen, Rasmus Mogelvang, Mette Bjerre, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2025
Characterisation of Leydig cell dysfunction in previous illicit androgen usersYeliz Bulut, Niels Brandt-Jacobsen, Rasmus Madsen, et al.
The Journal of Clinical Endocrinology and Metabolism|August 30, 2007
Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutationsHoracio M Domené, Paula A Scaglia, Aida Lteif, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|June 14, 2011
Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndromeRasmus Sode-Carlsen, Stense Farholt, Kai Fr Rabben, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|January 22, 2011
Lack of circulating bioactive and immunoreactive IGF-I changes despite improved fitness in chronic kidney disease patients following 48 weeks of physical trainingSara M Gregory, Samuel A Headley, Michael Germain, et al.
The Journal of Physiology|April 19, 2008
Ethinyl oestradiol administration in women suppresses synthesis of collagen in tendon in response to exerciseMette Hansen, Satu O Koskinen, Susanne G Petersen, et al.
Scandinavian Journal of Gastroenterology|November 4, 2005
Insulin-like growth factors (IGFs) and IGF binding proteins in active Crohn's disease treated with omega-3 or omega-6 fatty acids and corticosteroidsMartin Eivindson, Henning Grønbaek, Jens Nederby Nielsen, et al.
The Journal of Clinical Endocrinology and Metabolism|July 29, 2016
Growth Hormone and Insulin Signaling in Acromegaly: Impact of Surgery Versus Somatostatin Analog TreatmentJakob Dal, Katrine Lundby Høyer, Steen Bønløkke Pedersen, et al.
Pageof 30